期刊
SCHIZOPHRENIA RESEARCH
卷 227, 期 -, 页码 52-60出版社
ELSEVIER
DOI: 10.1016/j.schres.2020.05.007
关键词
Precision psychiatry; Feasibility; Implementation; Psychosis; transdiagnostic; Risk calculator
类别
资金
- King's College London Confidence in Concept award fromtheMedical Research Council (MRC) [MC_PC_16048]
- UK Medical Research Council [MR/N013700/1]
- King's College London
- MRC Health Data Research UK Fellowship [MR/S003118/1]
- Academy of Medical Sciences [SGL015/1020]
- Wellcome Trust
- MRC
- British Heart Foundation
- Arthritis Research UK
- Royal College of Physicians
- Diabetes UK
- National Institute for Health Research (NIHR) Biomedical Research Centre at the South London
- Maudsley NHS Foundation Trust
- EPSRC [EP/N027280/1] Funding Source: UKRI
- MRC [MR/S003118/1, MC_PC_17214, MC_PC_16048] Funding Source: UKRI
This study demonstrates the feasibility of implementing an individualized, transdiagnostic risk calculator to automatically screen Electronic Health Records (EHRs) for individuals at-risk for psychosis. Findings suggest that combining precision psychiatry and EHR methods can improve detection of individuals with emerging psychosis. Further research is needed to explore the potential of this approach in psychiatric practice.
Background: Risk estimation models integrated into Electronic Health Records (EHRs) can deliver innovative approaches in psychiatry, but dinicians' endorsement and their real-world usability are unknown. This study aimed to investigate the real-world feasibility of implementing an individualised, transdiagnostic risk calculator to automatically screen EHRs and detect individuals at-risk for psychosis. Methods: Feasibility implementation study encompassing an in-vitro phase (March 2018 to May 2018) and invivo phase (May 2018 to April 2019). The in-vitro phase addressed implementation barriers and embedded the risk calculator (predictors: age, gender, ethnicity, index duster diagnosis, age*gender) into the local EHR. The in-vivo phase investigated the real-world feasibility of screening individuals accessing secondary mental healthcare at the South London and Maudsley NHS Trust. The primary outcome was adherence of clinicians to automatic EHR screening, defined by the proportion of dinicians who responded to alerts from the risk calculator, over those contacted. Results: In-vitro phase: implementation barriers were identified/overcome with clinician and service user engagement, and the calculator was successfully integrated into the local EHR through the CogStack platform. In-vivo phase: 3722 individuals were automatically screened and 115 were detected. Clinician adherence was 74% without outreach and 85% with outreach. One-third of clinicians responded to the first email (37.1%) or phone calls (33.7%). Among those detected, cumulative risk of developing psychosis was 12% at six-month follow-up. Conclusion: This is the first implementation study suggesting that combining precision psychiatry and EHR methods to improve detection of individuals with emerging psychosis is feasible. Future psychiatric implementation research is urgently needed. (C) 2020 The Authors. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据